Everyone experiences nosebleeds at some point, but nosebleeds with no known cause can be a sign of hemophilia, according to ...

Even with two diagnosed bleeding disorders, columnist Jennifer Lynne still hesitates to identify a bleed due to years of medical dismissal.

People with severe hemophilia A are at risk for prolonged bleeding events that can cause serious complications. To prevent these bleeding events, most people with this condition get injections of ...

The annual rate of bleeding was 1.7 with Alhemo compared with 11.8 for people that received no prophylaxis, which was an 86% decrease. There were no differences in bodily pain and physical ...

BioMarin's Roctavian gene therapy shows long-term effectiveness in treating severe hemophilia A, reducing bleeding and ...

Patients with hemophilia across the spectrum still face regular challenges like frequent bleeding episodes, joint damage, and chronic pain, which negatively impact their quality of life.

A soon-to-be-released documentary film aims to change the conversation around hemophilia, a condition in which many female ...

Topline data were announced from a phase 3 trial evaluating marstacimab for adults and adolescents living with hemophilia A or B with inhibitors. Marstacimab is a tissue factor pathway inhibitor ...

Pfizer's gene therapy for hemophilia A significantly cut the number of annual bleeding episodes in patients with the rare disorder in a late-stage study and performed better than the current ...

At first, the Abereggs found help from a local bleeding disorders patient group. Then, a friend from that community introduced them to the Coalition for Hemophilia B, an organization focused ...